IMP: BOD resolution dated November 29, 2022

HOSE - 01/12/2022 3:57:00 PM


  The Board resolution dated November 29, 2022, the Board of Directors of Imexpharm Corporation approved to use the Development Investment Fund to compensate for the Conpany’s operating expenses in 2022 with total amount of VND10,560,521,135.

File đính kèm:

Các tin liên quan